Human-like antibodies neutralizing Western equine encephalitis virus

References

• Hahn CS, Lustig S, Strauss EG, Strauss JH. Western equine encephalitis virus is a recombinant virus. Proc Natl Acad Sci U S A 1988; 85:5997 - 6001; http://dx.doi.org/10.1073/pnas.85.16.5997; PMID: 3413072
   PubMed Web of Science ®Google Scholar
• Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, Weaver SC. Evolutionary relationships and systematics of the alphaviruses. J Virol 2001; 75:10118 - 31; http://dx.doi.org/10.1128/JVI.75.21.10118-10131.2001; PMID: 11581380
   PubMed Web of Science ®Google Scholar
• Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 1994; 58:491 - 562; PMID: 7968923
   PubMedGoogle Scholar
• Sherman MB, Weaver SC. Structure of the recombinant alphavirus Western equine encephalitis virus revealed by cryoelectron microscopy. J Virol 2010; 84:9775 - 82; http://dx.doi.org/10.1128/JVI.00876-10; PMID: 20631130
   PubMed Web of Science ®Google Scholar
• Giltner LT, Shahan MS. The immunological relationship of eastern and western strains of equine encephalomyelitis virus. Science 1933; 78:587 - 8; http://dx.doi.org/10.1126/science.78.2034.587-a; PMID: 17801697
   PubMedGoogle Scholar
• King LS. Studies on eastern equine encephalomyelitis : III. intraocular infection with fixed virus in the guinea pig. J Exp Med 1939; 69:691 - 704; http://dx.doi.org/10.1084/jem.69.5.691; PMID: 19870871
   PubMedGoogle Scholar
• Kubes V, Ríos FA. The causative agent of infectious equine encephalomyelitis in venezuela. Science 1939; 90:20 - 1; http://dx.doi.org/10.1126/science.90.2323.20; PMID: 17818578
   PubMedGoogle Scholar
• Weaver SC, Ferro C, Barrera R, Boshell J, Navarro J-C. Venezuelan equine encephalitis. Annu Rev Entomol 2004; 49:141 - 74; http://dx.doi.org/10.1146/annurev.ento.49.061802.123422; PMID: 14651460
   PubMed Web of Science ®Google Scholar
• Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol 2010; 140:281 - 6; http://dx.doi.org/10.1016/j.vetmic.2009.08.023; PMID: 19775836
   PubMed Web of Science ®Google Scholar

• Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994; 7:89 - 116; PMID: 8118792
   PubMed Web of Science ®Google Scholar
• Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997; 336:1867 - 74; http://dx.doi.org/10.1056/NEJM199706263362604; PMID: 9197215
   PubMed Web of Science ®Google Scholar
• Feemster RF. Outbreak of Encephalitis in Man Due to the Eastern Virus of Equine Encephalomyelitis. Am J Public Health Nations Health 1938; 28:1403 - 10; http://dx.doi.org/10.2105/AJPH.28.12.1403; PMID: 18014957
   PubMedGoogle Scholar
• Leitenberg M. Biological weapons in the twentieth century: a review and analysis. Crit Rev Microbiol 2001; 27:267 - 320; http://dx.doi.org/10.1080/20014091096774; PMID: 11791799
   PubMed Web of Science ®Google Scholar
• Letson GW, Bailey RE, Pearson J, Tsai TF. Eastern equine encephalitis (EEE): a description of the 1989 outbreak, recent epidemiologic trends, and the association of rainfall with EEE occurrence. Am J Trop Med Hyg 1993; 49:677 - 85; PMID: 8279635
   PubMed Web of Science ®Google Scholar
• Mossel EC, Ledermann JP, Phillips AT, Borland EM, Powers AM, Olson KE. Molecular determinants of mouse neurovirulence and mosquito infection for Western equine encephalitis virus. PLoS One 2013; 8:e60427; http://dx.doi.org/10.1371/journal.pone.0060427; PMID: 23544138
   PubMedGoogle Scholar
• Rivas F, Diaz LA, Cardenas VM, Daza E, Bruzon L, Alcala A, De la Hoz O, Caceres FM, Aristizabal G, Martinez JW, et al. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis 1997; 175:828 - 32; http://dx.doi.org/10.1086/513978; PMID: 9086137
   PubMed Web of Science ®Google Scholar
• Rozdilsky B, Robertson HE, Chorney J. Western encephalitis: report of eight fatal cases. Saskatchewan epidemic, 1965. Can Med Assoc J 1968; 98:79 - 86; PMID: 5688720
   PubMed Web of Science ®Google Scholar
• Sanchez JL, Takafuji ET, Lednar WM, LeDuc JW, Macasaet FF, Mangiafico JA, Rosato RR, Driggers DP, Haecker JC. Venezuelan equine encephalomyelitis: report of an outbreak associated with jungle exposure. Mil Med 1984; 149:618 - 21; PMID: 6438552
   PubMed Web of Science ®Google Scholar
• Sudia WD, McLean RG, Newhouse VF, Johnston JG, Miller DL, Trevino H, Bowen GS, Sather G. Epidemic Venezuelan equine encephalitis in North America in 1971: vertebrate field studies. Am J Epidemiol 1975; 101:36 - 50; PMID: 1119481
   PubMed Web of Science ®Google Scholar
• Swayze RD, Bhogal HS, Barabé ND, McLaws LJ, Wu JQH. Envelope protein E1 as vaccine target for western equine encephalitis virus. Vaccine 2011; 29:813 - 20; http://dx.doi.org/10.1016/j.vaccine.2010.11.009; PMID: 21084062
   PubMed Web of Science ®Google Scholar
• Delfraro A, Burgueño A, Morel N, González G, García A, Morelli J, Pérez W, Chiparelli H, Arbiza J. Fatal human case of Western equine encephalitis, Uruguay. Emerg Infect Dis 2011; 17:952 - 4; http://dx.doi.org/10.3201/eid1705.101068; PMID: 21529429
   PubMed Web of Science ®Google Scholar
• Reeves WC, Hutson GA, Bellamy RE, Scrivani RP. Chronic latent infections of birds with Western equine encephalomyelitis virus. Proc Soc Exp Biol Med 1958; 97:733 - 6; http://dx.doi.org/10.3181/00379727-97-23862; PMID: 13554464
   PubMed Web of Science ®Google Scholar
• Logue CH, Bosio CF, Welte T, Keene KM, Ledermann JP, Phillips A, Sheahan BJ, Pierro DJ, Marlenee N, Brault AC, et al. Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model. J Gen Virol 2009; 90:1848 - 58; http://dx.doi.org/10.1099/vir.0.008656-0; PMID: 19403754
   PubMed Web of Science ®Google Scholar
• Nagata LP, Hu W-G, Parker M, Chau D, Rayner GA, Schmaltz FL, Wong JP. Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. J Gen Virol 2006; 87:2353 - 61; http://dx.doi.org/10.1099/vir.0.81815-0; PMID: 16847131
   PubMed Web of Science ®Google Scholar
• Phillpotts RJ. Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III. Virus Res 2006; 120:107 - 12; http://dx.doi.org/10.1016/j.virusres.2006.02.003; PMID: 16621103
   PubMed Web of Science ®Google Scholar
• Reed DS, Larsen T, Sullivan LJ, Lind CM, Lackemeyer MG, Pratt WD, Parker MD. Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. J Infect Dis 2005; 192:1173 - 82; http://dx.doi.org/10.1086/444397; PMID: 16136459
   PubMed Web of Science ®Google Scholar
• Hawley RJ, Eitzen EM Jr.. Biological weapons--a primer for microbiologists. Annu Rev Microbiol 2001; 55:235 - 53; http://dx.doi.org/10.1146/annurev.micro.55.1.235; PMID: 11544355
   PubMed Web of Science ®Google Scholar
• Sidwell RW, Smee DF. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res 2003; 57:101 - 11; http://dx.doi.org/10.1016/S0166-3542(02)00203-6; PMID: 12615306
   PubMed Web of Science ®Google Scholar
• Nagata LP, Wong JP, Hu W-G, Wu JQ. Vaccines and therapeutics for the encephalitic alphaviruses. Future Virol 2013; 8:661 - 74; http://dx.doi.org/10.2217/fvl.13.42
   Web of Science ®Google Scholar
• Atasheva S, Wang E, Adams AP, Plante KS, Ni S, Taylor K, Miller ME, Frolov I, Weaver SC. Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus. Vaccine 2009; 27:4309 - 19; http://dx.doi.org/10.1016/j.vaccine.2009.05.011; PMID: 19446595
   PubMed Web of Science ®Google Scholar
• Barabé ND, Rayner GA, Christopher ME, Nagata LP, Wu JQH. Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus. Vaccine 2007; 25:6271 - 6; http://dx.doi.org/10.1016/j.vaccine.2007.05.054; PMID: 17630056
   PubMed Web of Science ®Google Scholar
• Wu JQH, Barabé ND, Chau D, Wong C, Rayner GR, Hu W-G, Nagata LP. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine. Vaccine 2007; 25:4368 - 75; http://dx.doi.org/10.1016/j.vaccine.2007.03.042; PMID: 17467858
   PubMed Web of Science ®Google Scholar
• Nagata LP, Hu W-G, Masri SA, Rayner GA, Schmaltz FL, Das D, Wu J, Long MC, Chan C, Proll D, et al. Efficacy of DNA vaccination against western equine encephalitis virus infection. Vaccine 2005; 23:2280 - 3; http://dx.doi.org/10.1016/j.vaccine.2005.01.032; PMID: 15755611
   PubMed Web of Science ®Google Scholar
• Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine. Vaccine 2009; 27:4152 - 60; http://dx.doi.org/10.1016/j.vaccine.2009.04.049; PMID: 19406186
   PubMed Web of Science ®Google Scholar
• Logue CH, Phillips AT, Mossel EC, Ledermann JP, Welte T, Dow SW, Olson KE, Powers AM. Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge. Antiviral Res 2010; 87:195 - 203; http://dx.doi.org/10.1016/j.antiviral.2010.04.013; PMID: 20452378
   PubMed Web of Science ®Google Scholar
• Phillips AT, Stauft CB, Aboellail TA, Toth AM, Jarvis DL, Powers AM, Olson KE. Bioluminescent imaging and histopathologic characterization of WEEV neuroinvasion in outbred CD-1 mice. PLoS One 2013; 8:e53462; http://dx.doi.org/10.1371/journal.pone.0053462; PMID: 23301074
   PubMedGoogle Scholar
• Das D, Kriangkum J, Nagata LP, Fulton RE, Suresh MR. Development of a biotin mimic tagged ScFv antibody against western equine encephalitis virus: bacterial expression and refolding. J Virol Methods 2004; 117:169 - 77; http://dx.doi.org/10.1016/j.jviromet.2004.01.008; PMID: 15041214
   PubMed Web of Science ®Google Scholar
• Xu B, Kriangkum J, Nagata LP, Fulton RE, Suresh MR. A single chain Fv specific against Western equine encephalitis virus. Hybridoma 1999; 18:315 - 23; http://dx.doi.org/10.1089/hyb.1999.18.315; PMID: 10571261
   PubMed Web of Science ®Google Scholar
• Long MC, Jager S, Mah DC, Jebailey L, Mah MA, Masri SA, Nagata LP. Construction and characterization of a novel recombinant single-chain variable fragment antibody against Western equine encephalitis virus. Hybridoma 2000; 19:1 - 13; http://dx.doi.org/10.1089/027245700315743; PMID: 10768836
   PubMed Web of Science ®Google Scholar
• Avril A, Froude JW, Mathieu J, Pelat T, Thullier P. Isolation of antibodies from non-human primates for clinical use. Curr Drug Discov Technol 2014; 11:20 - 7; http://dx.doi.org/10.2174/15701638113109990030; PMID: 23410051
   PubMedGoogle Scholar
• Pelat T, Hust M, Thullier P. Obtention and engineering of non-human primate (NHP) antibodies for therapeutics. Mini Rev Med Chem 2009; 9:1633 - 8; http://dx.doi.org/10.2174/138955709791012283; PMID: 20105119
   PubMed Web of Science ®Google Scholar
• Duggan JM, Coates DM, Ulaeto DO. Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources. Viral Immunol 2001; 14:263 - 73; http://dx.doi.org/10.1089/088282401753266774; PMID: 11572636
   PubMed Web of Science ®Google Scholar
• Hunt AR, Frederickson S, Maruyama T, Roehrig JT, Blair CD. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity. PLoS Negl Trop Dis 2010; 4:e739; http://dx.doi.org/10.1371/journal.pntd.0000739; PMID: 20644615
   PubMed Web of Science ®Google Scholar
• Kirsch MI, Hülseweh B, Nacke C, Rülker T, Schirrmann T, Marschall H-J, Hust M, Dübel S. Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol 2008; 8:66; http://dx.doi.org/10.1186/1472-6750-8-66; PMID: 18764933
   PubMed Web of Science ®Google Scholar
• Rülker T, Voß L, Thullier P, O’ Brien LM, Pelat T, Perkins SD, Langermann C, Schirrmann T, Dübel S, Marschall H-J, et al. Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo. PLoS One 2012; 7:e37242; http://dx.doi.org/10.1371/journal.pone.0037242; PMID: 22666347
   PubMed Web of Science ®Google Scholar
• Hust M, Meyer T, Voedisch B, Rülker T, Thie H, El-Ghezal A, Kirsch MI, Schütte M, Helmsing S, Meier D, et al. A human scFv antibody generation pipeline for proteome research. J Biotechnol 2011; 152:159 - 70; http://dx.doi.org/10.1016/j.jbiotec.2010.09.945; PMID: 20883731
   PubMed Web of Science ®Google Scholar
• Rondot S, Koch J, Breitling F, Dübel S. A helper phage to improve single-chain antibody presentation in phage display. Nat Biotechnol 2001; 19:75 - 8; http://dx.doi.org/10.1038/83567; PMID: 11135557
   PubMed Web of Science ®Google Scholar
• Soltes G, Hust M, Ng KKY, Bansal A, Field J, Stewart DIH, Dübel S, Cha S, Wiersma EJ. On the influence of vector design on antibody phage display. J Biotechnol 2007; 127:626 - 37; http://dx.doi.org/10.1016/j.jbiotec.2006.08.015; PMID: 16996161
   PubMed Web of Science ®Google Scholar
• Jäger V, Büssow K, Wagner A, Weber S, Hust M, Frenzel A, Schirrmann T. High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol 2013; 13:52; http://dx.doi.org/10.1186/1472-6750-13-52; PMID: 23802841
   PubMed Web of Science ®Google Scholar
• Greiser-Wilke I, Moenning V, Kaaden OR, Figueiredo LT. Most alphaviruses share a conserved epitopic region on their nucleocapsid protein. J Gen Virol 1989; 70:743 - 8; http://dx.doi.org/10.1099/0022-1317-70-3-743; PMID: 2471798
   PubMed Web of Science ®Google Scholar
• Wu JQH, Barabé ND, Huang Y-M, Rayner GA, Christopher ME, Schmaltz FL. Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha. Virology 2007; 369:206 - 13; http://dx.doi.org/10.1016/j.virol.2007.07.024; PMID: 17761207
   PubMed Web of Science ®Google Scholar
• Sabin AB. Quantitative studies on prophylactic effectiveness of western equine encephalitis antiserum in mice. Proc Soc Exp Biol Med 1951; 78:655 - 8; http://dx.doi.org/10.3181/00379727-78-19172; PMID: 14911984
   PubMed Web of Science ®Google Scholar
• Reichert E, Clase A, Bacetty A, Larsen J. Alphavirus antiviral drug development: scientific gap analysis and prospective research areas. Biosecur Bioterror 2009; 7:413 - 27; http://dx.doi.org/10.1089/bsp.2009.0032; PMID: 20028250
   PubMed Web of Science ®Google Scholar
• Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RTP, Bertin-Maghit S, Ng LFP, Abastado J-P, Desprès P, et al. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J Immunol 2011; 186:3258 - 64; http://dx.doi.org/10.4049/jimmunol.1003139; PMID: 21278338
   PubMed Web of Science ®Google Scholar
• Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I, Akahata W, Nabel GJ, Richter MKS, et al. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog 2013; 9:e1003312; http://dx.doi.org/10.1371/journal.ppat.1003312; PMID: 23637602
   PubMed Web of Science ®Google Scholar
• Roehrig JT, Day JW, Kinney RM. Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 1982; 118:269 - 78; http://dx.doi.org/10.1016/0042-6822(82)90346-4; PMID: 6178209
   PubMed Web of Science ®Google Scholar
• Goodchild SA, O’Brien LM, Steven J, Muller MR, Lanning OJ, Logue CH, D’Elia RV, Phillpotts RJ, Perkins SD. A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus. Antiviral Res 2011; 90:1 - 8; http://dx.doi.org/10.1016/j.antiviral.2011.01.010; PMID: 21310183
   PubMed Web of Science ®Google Scholar
• Hunt AR, Frederickson S, Hinkel C, Bowdish KS, Roehrig JT. A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus. J Gen Virol 2006; 87:2467 - 76; http://dx.doi.org/10.1099/vir.0.81925-0; PMID: 16894184
   PubMed Web of Science ®Google Scholar
• Hu W-G, Phelps AL, Jager S, Chau D, Hu CC, O’Brien LM, Perkins SD, Gates AJ, Phillpotts RJ, Nagata LP. A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus. Vaccine 2010; 28:5558 - 64; http://dx.doi.org/10.1016/j.vaccine.2010.06.038; PMID: 20600509
   PubMed Web of Science ®Google Scholar
• O’Brien LM, Underwood-Fowler CD, Goodchild SA, Phelps AL, Phillpotts RJ. Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains. Virol J 2009; 6:206; http://dx.doi.org/10.1186/1743-422X-6-206; PMID: 19925641
   PubMed Web of Science ®Google Scholar
• Pelat T, Hust M, Laffly E, Condemine F, Bottex C, Vidal D, Lefranc M-P, Dübel S, Thullier P. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother 2007; 51:2758 - 64; http://dx.doi.org/10.1128/AAC.01528-06; PMID: 17517846
   PubMed Web of Science ®Google Scholar
• Chahboun S, Hust M, Liu Y, Pelat T, Miethe S, Helmsing S, Jones RG, Sesardic D, Thullier P. Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin. BMC Biotechnol 2011; 11:113; http://dx.doi.org/10.1186/1472-6750-11-113; PMID: 22111995
   PubMed Web of Science ®Google Scholar
• Pelat T, Hust M, Hale M, Lefranc M-P, Dübel S, Thullier P. Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol 2009; 9:60; http://dx.doi.org/10.1186/1472-6750-9-60; PMID: 19563687
   PubMed Web of Science ®Google Scholar
• Laffly E, Danjou L, Condemine F, Vidal D, Drouet E, Lefranc M-P, Bottex C, Thullier P. Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Antimicrob Agents Chemother 2005; 49:3414 - 20; http://dx.doi.org/10.1128/AAC.49.8.3414-3420.2005; PMID: 16048955
   PubMed Web of Science ®Google Scholar
• Pelat T, Bedouelle H, Rees AR, Crennell SJ, Lefranc M-P, Thullier P. Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J Mol Biol 2008; 384:1400 - 7; http://dx.doi.org/10.1016/j.jmb.2008.10.033; PMID: 18976662
   PubMed Web of Science ®Google Scholar
• USDA Animal Welfare Act (AWA). 7 U.S.C. 2131 et seq., as amended and Health Research Extension Act of 1985 (“‘Animals in Research’”). 1985.
   Google Scholar
• National Research Council. Guide for the Care and Use of Laboratory Animals. Eighth Edition. Washington: The National Academies Press; 2011.
   Google Scholar
• Huelseweh B, Ehricht R, Marschall H-J. A simple and rapid protein array based method for the simultaneous detection of biowarfare agents. Proteomics 2006; 6:2972 - 81; http://dx.doi.org/10.1002/pmic.200500721; PMID: 16622830
   PubMed Web of Science ®Google Scholar
• Sagripanti J-L, Hülseweh B, Grote G, Voss L, Böhling K, Marschall H-J. Microbial inactivation for safe and rapid diagnostics of infectious samples. Appl Environ Microbiol 2011; 77:7289 - 95; http://dx.doi.org/10.1128/AEM.05553-11; PMID: 21856830
   PubMed Web of Science ®Google Scholar
• Hamilton MA, Russo RC, Thurston RV. Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays. Enviromental Sci Technol 1977; 11:714 - 9; http://dx.doi.org/10.1021/es60130a004
   Web of Science ®Google Scholar
• Schütte M, Thullier P, Pelat T, Wezler X, Rosenstock P, Hinz D, Kirsch MI, Hasenberg M, Frank R, Schirrmann T, et al. Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One 2009; 4:e6625; http://dx.doi.org/10.1371/journal.pone.0006625; PMID: 19675673
   PubMed Web of Science ®Google Scholar
• Frenzel A, Kügler J, Wilke S, Schirrmann T, Hust M. Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol 2014; 1060:215 - 43; http://dx.doi.org/10.1007/978-1-62703-586-6_12; PMID: 24037844
   PubMedGoogle Scholar
• Sambrook J, Russell D. Molecular cloning: a laboratory manual. 3nd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
   Google Scholar
• Henchal EA, Gentry MK, McCown JM, Brandt WE. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 1982; 31:830 - 6; PMID: 6285749
   PubMed Web of Science ®Google Scholar
• Greiser-Wilke IM, Moennig V, Kaaden OR, Shope RE. Detection of alphaviruses in a genus-specific antigen capture enzyme immunoassay using monoclonal antibodies. J Clin Microbiol 1991; 29:131 - 7; PMID: 1847149
   PubMed Web of Science ®Google Scholar
• Jensen MH. Detection of antibodies against hog cholera virus and bovine viral diarrhea virus in porcine serum. A comparative examination using CF, PLA and NPLA assays. Acta Vet Scand 1981; 22:85 - 98; PMID: 6266240
   PubMed Web of Science ®Google Scholar